KN

Kunal Navin Saxena

Active Director Director DIN 05267911
DIN 05267911 First appointment Apr 2012 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 9 active board seats
Past companies –
Total affiliations 9 Since Apr 2012
Shareholding value •••• Premium profile

About Kunal Navin Saxena

Data last updated:

Kunal Navin Saxena has 14 years in corporate governance. Holds Director and Managing Director roles. Currently with 9 companies, including Navicare Pharma Private Limited and Rusan Health Care Private Limited. Engaged in General Business, Healthcare and more. Contributes to corporate operations. The 8 current companies with reported revenue have a combined latest revenue of ₹440 Cr; the largest is Rusan Pharma Limited at ₹392 Cr (FY 2025).

DIN 05267911
Primary Designation Director
First Appointment 05 Apr 2012
Oldest Company Age 32 yrs
Largest company Rusan Pharma Limited · ₹392 Cr (FY 2025)
Combined revenue ₹440 Cr across 8 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rusan Pharma Limited U24230MH1994PLC077069
Managing Director05 Apr 20121994₹392 Cr (FY 2025)Active
Rusan Health Care Private Limited U24200MH1999PTC122536
Director19 Apr 20131999₹31.60 Cr (FY 2024)Active
Director19 Apr 20131994₹13.34 Cr (FY 2025)Active
Quantys Clinical Private Limited U74120MH2014PTC257021
Director08 Aug 20142014₹1.56 Cr (FY 2025)Active
Navicare Pharma Private Limited U24110MH2011PTC216977
Director19 Apr 20132011₹62.6 Lakh (FY 2024)Active
Tuscany Holdings Private Limited U65990MH1994PTC081494
Director17 Oct 20121994₹26.9 Lakh (FY 2025)Active
Director06 Sep 20222022₹5 Lakh (FY 2025)Active
Director19 Apr 20131998₹1.6 Lakh (FY 2024)Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Navicare Pharma Private Limited
Rusan Health Care Private Limited
Rusan Pharma Limited
Euromed International Private Limited
Premium access

Shareholding and investment profile for Kunal Navin Saxena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kunal Navin Saxena

Kunal Navin Saxena has 14 years in corporate governance. Holds Director and Managing Director roles. Currently with 9 companies, including Navicare Pharma Private Limited and Rusan Health Care Private Limited. Engaged in General Business, Healthcare and more. Contributes to corporate operations. The 8 current companies with reported revenue have a combined latest revenue of ₹440 Cr; the largest is Rusan Pharma Limited at ₹392 Cr (FY 2025).

Kunal Navin Saxena is associated with 9 companies as Director and Managing Director, including Rusan Pharma Limited (₹392 Cr), Rusan Health Care Private Limited (₹31.60 Cr), Navin Saxena Research And Technology Private Limited (₹13.34 Cr).

Kunal Navin Saxena has expertise in General Business, Healthcare and other sectors.

Kunal Navin Saxena has 14 years in corporate governance.

By reported revenue, the largest current company of Kunal Navin Saxena is Rusan Pharma Limited, with revenue of ₹392 Cr (FY 2025).

The 8 current companies of Kunal Navin Saxena that report revenue have a combined latest revenue of ₹440 Cr.

Kunal Navin Saxena currently holds positions at 9 companies; the 5 largest by reported revenue are Rusan Pharma Limited (₹392 Cr), Rusan Health Care Private Limited (₹31.60 Cr), Navin Saxena Research And Technology Private Limited (₹13.34 Cr), Quantys Clinical Private Limited (₹1.56 Cr), Navicare Pharma Private Limited (₹62.6 Lakh).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available